Skip to main content

Table 3 Committee feedback in relation to progression criteria by application stage and outcome

From: Inclusion of progression criteria in external randomised pilot trials: a cross-sectional study of funding applications submitted to the NIHR Research for Patient Benefit Programme

 

Outline application (Stage 1)

Full application (Stage 2)

Total

Invited

Rejected

Total

Awarded

Rejected

Funding committee feedback explicitly mentions progression criteria

(n = 95)

(n = 52)

(n = 43)

(n = 49)

(n = 35)

(n = 14)

 Yes

22 (23%)

15 (29%)

7 (16%)

11 (22%)

9 (26%)

2 (14%)

  Progression criteria stipulated

10 (45%)

7 (47%)

3 (43%)

7 (64%)

5 (56%)

2 (100%)

  Progression criteria not stipulated

12 (55%)

8 (53%)

4 (57%)

4 (36%)

4 (44%)

0 (0%)

 No

73 (77%)

37 (71%)

36 (84%)

38 (78%)

26 (74%)

12 (86%)

  Progression criteria stipulated

38 (52%)

17 (46%)

21 (58%)

29 (76%)

21 (81%)

8 (67%)

  Progression criteria not stipulated

35 (48%)

20 (54%)

15 (42%)

9 (24%)

5 (19%)

4 (33%)

Details of feedback where stipulated

(n = 22)

(n = 15)

(n = 7)

(n = 11)

(n = 9)

(n = 2)

 Feedback implies progression criteria were not stipulated

11 (50%)

7 (47%)

4 (57%)

4 (36%)

4 (44%)

0 (0%)

 Feedback requests further detail/clarity e.g. numerical thresholds

8 (36%)

5 (33%)

3 (43%)

3 (27%)

3 (33%)

0 (0%)

 Feedback relates to rationale or justification for progression criteria

3 (14%)

3 (20%)

0 (0%)

4 (36%)

2 (22%)

2 (100%)

  1. 95 Stage 1 applications were included, 52 were invited to Stage 2, three were ineligible and 49 were included